Duality Advisers’s W.R. Berkley WRB Stock Holding History

Duality Advisers’s Portfolio WRB Stock Details WRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,512	Closed	-$657K	–	765
2023 Q3	$657K	Buy	+15,512	New	+$643K	0.08%	371
2023 Q2	–	Sell	-39,075	Closed	-$1.62M	–	762
2023 Q1	$1.62M	Sell	39,075 -1,358	-3%	-$60.8K	0.18%	204
2022 Q4	$1.96M	Buy	+40,433	New	+$1.95M	0.22%	162

Other funds holding WRB

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Duality Advisers's WRB Position: Q4 2023 in Review

Duality Advisers sold out of W.R. Berkley (WRB) in Q4 2023, closing a stake of 15,512 shares — an estimated $657K sold.

Duality Advisers first reported a position in WRB in Q4 2022 and held it in 3 quarters. The position peaked at $1.96M in Q4 2022. 725 funds tracked by Wall St. Rank hold WRB as of Q4 2023.

Duality Advisers reported no remaining W.R. Berkley position as of Q4 2023 after selling out during the quarter.
Duality Advisers sold 15,512 W.R. Berkley shares in Q4 2023, an estimated $657K.
Duality Advisers first reported a position in W.R. Berkley in Q4 2022 and held it in 3 quarters.
Duality Advisers's W.R. Berkley position peaked at $1.96M in Q4 2022.
725 funds tracked by Wall St. Rank held W.R. Berkley as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.